Skip to main content
Topics
Video
Provider
Payer
Pharma
ANZ
ASIA
EMEA
Global Edition
Biolinq
Biolinq raises $100M for intradermal glucose sensor for type 2 diabetes
By
Jessica Hagen
|
12:26 pm |
April 22, 2025
The company's patch uses intradermal electrochemical sensors to monitor glucose levels and provide metabolic insights to individuals with type 2 diabetes not on insulin.